Chat with us, powered by LiveChat
Multi-Stakeholder Commercial Model Summit -

Multi-Stakeholder Commercial Model Summit
December 2 - 3, 2019
Boston, MA

Create Partnerships between physicians, patients, payers, providers, policy makers, partners, regulators, and shareholders for improved collaborations

Faculty – Multi-Stakeholder Commercial Model Summit


John Alter
VP, Patient and Health Impact Lead, Hospital Business Unit, PFIZER

view speaker profile

John Alter is currently Vice President, Global Health & Value lead and member of the leadership team of the Global Established Pharma Business Unit at Pfizer.  Health & Value functions include Pricing, Market Access, HEOR and Real World Data.

John joined Pfizer in 1998 and has held positions of increasing responsibilities in several functions/divisions including Corporate Finance, Global Manufacturing and Pharmaceutical Commercial Operations in North America, Latin America, Europe, Africa, Middle East and Asia Pacific.

John earned his undergraduate degree from Villanova University and his MBA from George Mason University and served as a U.S. Naval officer for six years before joining industry.  He is married with three children.


Raquel Cabo
Vice President, Global Market Access, OVID THERAPEUTICS

view speaker profile

Raquel has over ten years of experience across a variety of healthcare industry sectors in the US and Europe. Raquel is passionate about working with patients, clinicians, and payers at all stages of product development to address true unmet needs and ensure access.

Prior to joining Ovid, Raquel was Director of Global Market Access at GE Healthcare, based in London. In this role, she led a global team responsible for market access and health economics for new product introductions from the company’s imaging technology portfolio across all therapy areas. At GE Healthcare, Raquel focused on demonstrating the value of innovative technology through research, customer partnerships, digital marketing, and sales support.

Prior to GE, Raquel was a member of Medtronic’s EMEA health economics and reimbursement team, based in Switzerland. Before joining the industry, she was a neuropsychology specialist at Cogstate, a cognitive science start-up, and Columbia University Medical Center where she led operations for federally funded studies that evaluated the specificity of cognitive testing to diagnose Alzheimer’s Disease among minorities.

Raquel earned her MSc in International Health Policy and Health Economics from the London School of Economics and earned her BA in Psychology and French, cum laude, from the University of Pennsylvania. She is also a member of the University of Pennsylvania Fund executive board.


John Doyle, Ph.D.
Vice President, Global Healthcare Innovation Lead, PFIZER

Fasiha Haq
Global Medical Education Advisor, Rheumatology, and Consumer Care, BAYER

Rebecca Kirch
Executive VP, Healthcare Quality and Value, NATIONAL PATIENT ADVOCATE FOUNDATION

Christopher Mancill
Senior Vice President, Market Access and Policy, MORPHOSYS

Maureen McKenna
Business Mentor, RETURN ON ENERGY

Jennifer Muszik
U.S. Commercial Learning Lead, BIOGEN

Michael J. Ruggiero
Senior Vice President, Global Healthcare Policy and External Affairs, CSL BEHRING

Matthew Smith
Global Lead, Strategy, Digital, and Operations, PFIZER

Doug Stover
Vice President, Global Head of Patient Experience and Technology Practice, UCB

Tamar Thompson
Head, Federal Executive Branch Strategy and State Government Affairs, BRISTOL-MYERS SQUIBB

Melissa Williams
Manager of Health Care Policy and Advocacy, NATIONAL PATIENT ADVOCATE FOUNDATION

Ross Youngs
Chief Executive Officer, BIOSORTIA PHARMACEUTICALS

live chat software